Papers
6
Total Citations
2,159
H-Index
5
About
Ian M. Thompson is a leading urologic oncologist whose work has fundamentally shaped the management of prostate and bladder cancer. His research centers on evidence-based clinical guidelines, surgical innovation, and long-term oncologic outcomes. Thompson chaired the 2007 update of the American Urological Association’s Guideline for the Management of Clinically Localized Prostate Cancer (over 1,100 citations), a landmark document that standardized treatment approaches. He is perhaps best known as the principal investigator of the RAZOR trial (760 citations), the first multicenter, randomized phase 3 study to demonstrate that robot-assisted radical cystectomy is non-inferior to open surgery for bladder cancer, with subsequent analyses confirming comparable recurrence and survival rates at three years. His earlier work also explored neoadjuvant therapy for high-risk prostate cancer and the impact of local treatment on metastatic progression. With over 2,000 citations across his most influential publications, Thompson’s contributions have directly influenced surgical practice and clinical decision-making worldwide, making him a pivotal figure in the modern era of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update1,112 citations · 2007
- 2
- 3
- 4
- 5
- 6